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Abstract
Background:  Pain and emesis are the two major complaints after day case surgery. Local
anaesthesia has become an important part of optimizing intra and post-operative pain treatment,
but is sometimes not entirely sufficient. The aim of the present study was to study the effect of
adding an ankle block to a multi-modal analgesic approach on the first 24-hour-need for rescue
analgesia in patients undergoing elective Hallux Valgus surgery.
Type of study: Prospective, randomized patient-blind study comparing ankle block with levo-
bupivacaine, lidocaine and Saline placebo control.
Methods: Ninety patients were studied comparing ankle block (15 cc) using levo-bupivacaine 2.5
mg/ml, lidocaine 10 mg/ml or placebo (saline) on day-case elective Hallux Valgus surgery, supported
by general anaesthesia in all cases. Primary study endpoint was number of patient's requiring oral
analgesics during the first 24 post-operative hours.
Results: Ankle block had no effect on need for rescue analgesia and pain ratings during the 1st 24
postoperative hours, there was no difference seen between placebo and any of the two active local
anaesthesia studied. The only differences seen was that both lidocaine and levo-bupivacaine
reduced the intra-operative need for anaesthetic (sevoflurane) and that levo-bupivacaine patients
had a lower need as compared to the lidocaine patients for oral analgesics during the afternoon of
surgery.
Conclusion: Adding a single shot ankle block to a multi-modal pain management strategy reduces
the need for intra-operative anaesthesia but has no major impact of need of rescue analgesics or
pain during the first 24-hour after surgery.
Background
Multi modal pain management has become standard of
care especially in day case surgery [1]. Local anaesthesia
applied prior to incision has been shown to have positive
effects on the postoperative course [2]. However, in many
cases this is not sufficient to relieve pain after surgery [3].
The impact of adding a peripheral nerve block to local
wound infiltration has not been studied in Hallux Valgus
surgery. Hypothetically it could decrease postoperative
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discomfort and pain, allowing the patient to mobilise
faster and with less rescue medication.
The aim of the present study was to evaluate the effects of
adding a single shot ankle block to a routine multi-modal
pain strategy for the management of Hallux Valgus sur-
gery performed under general anaesthesia.
Methods
After informed consent 90 healthy America Society of
Anesthesiology functional classes 1–2 patients undergo-
ing elective Hallux Valgus surgery ad modum Turan were
studied [4]. The study protocol, a prospective randomised
study of the effects of a single shot ankle block on the need
for rescue analgesia during the first 24 hours following
surgery was approved by Karolinska Institutet's local ethi-
cal committee. The patients were randomised into three
groups by closed envelope technique;
Group A had 15 cc levo-bupivacaine 2.5 mg/ml
Group B had 15 cc lidocaine 10 mg/ml
Group C Placebo Control had 15 cc of saline
The performance of the ankle block was; "the posterior
tibial nerve" by 5 cc posterior to the medial malleoli, "the
peroneal nerve, superficial and deep" by 6 cc on dorsum
of the foot and "the sural nerve" by 4 cc posterior to the
lateral malleoli.
All patients followed the routine pre and postoperative
protocol of our institution. They were asked to refrain
from eating for 6 hours and drinking for 2 hour prior to
surgery.
After establishment of an intravenous line all patients
were given 8 mg betamethasone, 0.3 mg alfentanil and 30
– 50 mg propofol. After sedation the patients received the
ankle block in accordance with the randomisation in a
single blinded fashion.
All patients also had 10 cc of 10 mg/ml lidocaine subcu-
taneous around the surgical incision given by the ortho-
paedic surgeon (IT) under sterile conditions right prior to
incision. A general anaesthesia was administered by
means of sevoflurane in oxygen/air by mask. Sevoflurane
was titrated according to clinical needs by the attending
anaesthetist (JJ). Sevoflurane concentrations were contin-
uously monitored by side-stream gas analysis. Peak end-
tidal and mean end-tidal sevoflurane concentrations were
recorded and used for evaluation of need for anaesthesia.
Immediately after surgery anaesthesia was discontinued
and the patients moved to the recovery area, if fully awake
and alert possibly bypassing conventional recovery room
stay. After arrival in recovery area all patients had an initial
oral dose of etoricoxib 120 mg and a loading dose of 30
mg/kg paracetamol.
Patients were discharged when awake, and ambulant with
minimal and acceptable levels of subjective pain (VAS <
4).
At discharge all patients were provided with take-home
analgesic medication; Etoricoxib 120 mg, paracetamol 1
gr. and dextropropoxyphene 100 mg. All patients were
provided with oral and written instruction about pain
management at home they were informed to take:
￿ Regularly etoricoxib 120 mg once daily
￿ Additional paracetamol 1 gr. oral when needed (up to
four grams daily), as initial pain therapy
￿ Additional dextropropoxyphene 100 mg oral if paraceta-
mol had reviled pain within 30 minutes
They were instructed to take patacetamol and dextropro-
poxyphene not by routine, but only when needed.
Patients were instructed to fill in a protocol for the first
postoperative day; 1st 24 post operative hours, need for
any pain medication; paracetamol and dextropropoxy-
phene, as well as pain ratings at a verbal pain scale; no
pain, little pain, pain, severe pain [5].
Statistics
Patients' demographics are presented as mean and stand-
ard deviation. All results are given as median and range.
None-parametric Chi-square test or Mann-Whitney U-test
when appropriate studied differences between groups.
The number of patients (30 in each group) was deter-
mined by a pre-study power analysis based on the find-
ings in a pilot study in our institution; need for additional
analgesics in the control (placebo) group of 70% and a
clinical relevant absolute reduction in patient taking addi-
tional analgesics of 30%, corresponding to clinical signif-
icant effect of an ankle block being that only 40% of
patients needing additional analgesics during the first
postoperative 24 hours with a power of 90 % at p < 0.05.
All statistics were made in StatView™ on a Macintosh com-
puter system.
Results
There was no significant difference in patient demograph-
ics Table 1. Nine procedures were a combination of a Hal-
lux Valgus ad modum Turan and a hammertoe procedure.
All surgery and anaesthesia was uneventful and no com-
plications or adverse effects were noticed. Duration ofJournal of Orthopaedic Surgery and Research 2007, 2:26 http://www.josr-online.com/content/2/1/26
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procedures was also the same in all three groups; mean
duration of surgery (knife to skin to closed wound) was
12 (9–22) minutes. The need for sevoflurane was higher
in the placebo group of patients (end tidal gas concentra-
tions were significantly lower in the levo-bupivacaine and
lidocaine patients) otherwise no differences could be seen
intra-operatively or during the early postoperative period,
until discharge (Table 2). Emergence was rapid and all
patients were safely "fast-tracked", by-passing the regular
recovery room, into a step-down area. Recovery times,
time to allowing drinking and intake of oral medication
and time to be eligible for discharge were also the same in
all three groups. All patients were discharged home safely
within 60 minutes from reaching the recovery area/step-
down unit. No patient required any rescue analgesia or
anti-emetics during the recovery period.
The number of patients that needed further oral analgesics
during the first 24 postoperative hours was 21, 9 and 17
out of 30 for the lidocaine, levo-bupivacaine and placebo
group of patients respectively with no significant differ-
ence between either of the two active treatments as com-
pared to placebo, Table 3. Levo-bupivacaine did not
significantly increase the number rescue analgesia-free
patients as compared to placebo (p < 0.052) a significant
difference was seen, when analysed separately, between
levo-bupivacaine and lidocaine groups of patients (p <
0.0036). When levo-bupivacaine was compared to the
combined group of patients' lidocaine and placebo con-
trol a significant difference was also noticed (p < 0.0058).
Pain ratings were overall low, and waste majority of
patients made pain ratings as no or little pain. Nine
patients (10%) made a rating of painful during afternoon
and 10 (11 %) in the evening on the day of surgery. In the
morning and afternoon on the 1st postoperative day 6
(7%) and 18 (20%) patients respectively scored the inten-
sity as painful. Five patients made a rating of severe pain on
1 occasion and 1 patient on 2 occasions, afternoon and
evening day of surgery. No difference in pain ratings was
seen between the groups figure 1.
No complications or adverse events were noticed during
the follow-up period.
Discussion
The interpretation of our results should be done with cau-
tion, as the study design is complex. Our study is negative;
we could not see any statistical significant difference
between the levo-bupivacaine or lidocaine block and pla-
cebo with regard to our primary study endpoint; number
of patients that needed oral pain medication during the
first 24 post operative hours. Interestingly though is that a
post hoc separate comparison between lidocaine and
levo-bupivacaine revealed significantly less patients tak-
ing any further pain medication after a levo-bupivacaine
block as compared to the lidocaine block. Also when the
patients that received the long-acting local anaesthetic
levo-bupivacaine was compared to the combined group
of patients either given the short acting lidocaine block or
placebo control a significant difference was observed in
Table 1: Patient's demographics
Lidocaine (n = 30) Levo-bupivacaine (n = 30) Placebo (n = 30)
Sex (male/female) 6/24 1/29 4/26
Age (year.) 45 ± 15 50 ± 12 46 ± 13
Weight (kg) 69 ± 12 65 ± 98 70 ± 17
Surgery HV/HV + "hammer toe" 28/2 26/4 27/3
HV Hallux Valgus
Table 2: Intra and post operative observations
Lidocaine (n = 30) Levo-bupivacaine (n = 30) Placebo (n = 30)
Surgery HV/comb 28/2 26/4 27/3
Duration of surgery (min.) 12.4 ± 2.1 12.4 ± 2.7 11.9 ± 1.6
Propofol (mg) 104 ± 36 106 ± 38 115 ± 31
Et Sevo peak (%)  1.38 ± 0.55 1.42 ± 0.40 1.85 ± 0.67 **
Et Sevo mean (%)  0.99 ± 0.35 1.03 ± 0.26 1.43 ± 0.45 **
OAAS 5 (min.) 8  ±  38  ±  38  ±  3
Discharge (min.) 40 ± 8 40 ± 9 42 ± 9
** p < 0.01 ANOVA
HV Hallux Valgus
Et Sevo end tidal concentration of sevoflurane
OAAS Observer Assessment of Alertness Scale (5 awake, 0 asleep not responding to noxious stimulation).Journal of Orthopaedic Surgery and Research 2007, 2:26 http://www.josr-online.com/content/2/1/26
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favour for the levo-bupivacaine block. No difference was
however found in the need for "further dextropropoxy-
phene rescue medication". Also pain ratings were similar
between the all three groups studied; the addition of 15 cc
of lidocaine 10 g/ml or levo-bupivacaine 2.5 mg/ml did
not affect pain ratings during the first 24 postoperative
hours as compared to placebo. We found also that adding
both 15 cc of levo-bupivacaine 2.5 mg/ml or lidocaine 10
mg/ml as an ankle block prior to surgery to a multimodal
pain management during Hallux Valgus surgery decreased
the need for intra-operative anaesthesia by decreasing the
concentration of sevoflurane needed; however no differ-
ence in emergence/recovery time characteristics was
noticed.
The use of local anaesthetic is not a new concept but a
basic component used in clinical practice all over the
world. It is important to take into account that all our
patient had local anaesthesia, lidocaine, applied locally by
the surgeon before skin incision. In order to achieve a
rapid onset lidocaine has been the tradition of use in our
institution for locally applied anaesthesia. It would of
course be of interest to study the effects on postoperative
pain by changing to or adding a long acting local anaes-
thetic to the locally applied block. Already in 1985 Porter
and Davis showed that injecting a long acting local anaes-
thetic into the pseudoartrosis immediately after skin clo-
sure gave better postoperative pain relief as compared to
placebo after Keller's procedure [6]. The hypothesis of the
present study was that adding an ankle block with a long
lasting local anaesthetic to the routine of local anaesthesia
with lidocaine would enhance postoperative analgesia
and reducing the need for further analgesics during the
first postoperative 24 hours. Similar to what we previously
found for intra-articular injection in knee arthroscopy [7].
We also hypothesized that the adding a short-acting block
lidocaine ankle block would provide the intra-operative
effects but without major contribution on protracted post-
operative pain course and the need for postoperative anal-
gesics after discharge. We used the technique for
providing a classic ankle block that was described already
1983 by Sarrafian et al [8]. A seemingly safe, simple and
cost effective approach; looking at a 3 puncture ankle
block with a plain classic lidocaine 1 % or long lasting low
concentration local anaesthetic, levo-bupivacaine 2.5 mg/
ml. Lately more sophisticated techniques have been
described. Casati and co-workers studied sciatic nerve
blocks and showed reassuring result from that technique
[9]. Reinhart et al combined lidocaine and ketorolac and
found the locally applied combination more effective
than lidocain used for the ankle block and intravenous
ketorolac [10]. Continuous infusion of long acting local
anaesthesia has also been described in Hallux Valgus sur-
gery with positive results [11,12]. It is important to recog-
nise that adding an ankle block is not entirely
uncomplicated; it is time consuming and entails both cost
and risk. Both lidocaine and levo-bupivacaine have a low
toxicity; still injecting 15 cc close to ankle arteries and
veins is associated with the potential risk for intravascular
injection and systemic toxicity.
It should indeed be acknowledged that our patients all
received a multi-modal analgesic regime. All patients
received both bethametasone and a small dose of alfen-
tanil right before induction of anaesthesia. Romunstad et
al has convincingly shown the analgesic effects of steroids
[13], improving not only pain but also overall patient sat-
isfaction. Furthermore, all patients received etoricoxib in
maximal recommended dose immediately after surgery in
combination with a loading dose of paracetamol. The use
of NSAIDs and Coxibs has been debated because of their
theoretical risk of causing impaired bone healing. The
positive effect of coxibs in fore foot surgery has, however
been shown both by Pollak and Desjardines [14,15]. The
clinical evidence for any major impact from short term
NSAID/Coxib therapy on the bone healing is not well
documented [16]. And the use of NSAID/Coxib has been
the routine at our department since long. The oral route
has been advocated as equally effective to intravenous
administration and has been the standard of care in our
institution over many years [17]. The 30 mg/kg dose Para-
Pain ratings in each group, percentage of patient Figure 1
Pain ratings in each group, percentage of patient. 
Lido = lidocaine, Lev = levo-bupivacaine, Plac = placebo ADS 
= afternoon day of surgery, EDS = evening day of surgery 
MPD = morning post operative day 1, APD = afternoon post 
operative day 1.
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Table 3: Primary Outcome need for rescue analgesics during the 
first 24 hours
Lidocaine 
(n = 30)
Levo-bupivacaine 
(n = 30)
Placebo 
(n = 30)
Paracetamol 15 4 12
Detropropoxyphene 65 5
No analgesia 9 * 21 13
Number of patients in each group
p < 0.05 as compared to the levo-bupivacaine group onlyPublish with BioMed Central    and   every 
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cetamol should guarantee an early therapeutic plasma
concentration [18].
One may argue that the patients were given an extensive
peri-operative analgesics regime and that in orthopaedic
day surgical procedures such as knee arthroscopy the need
for postoperative pain medication is not that extensive
[7]. It is recognized that Hallux Valgus surgery is associ-
ated with far more extensive postoperative pain than for
example a partial meniscectomy [11]. The power of the
study was based on the assumption that 70 % of the con-
trol group of patients would experience pain to that extent
that intake of further analgesic after discharge was needed.
We found a somewhat lower number, still 57 % of the
control patients required further analgesic, and in the
lidocaine group 70 % of patients required post discharge
analgesics. Whether the slightly higher need for further
analgesics in the lidocaine group is a sign of rebound pain
is beyond the scoop of this study.
Conclusion
When added to a multi-modal pain management a single-
shot ankle block was not enough to show any significant
difference in the need for further analgesic and did not
change the pain ratings during the first 24 hours after elec-
tive Hallux Valgus surgery as compared to placebo. Add-
ing an ankle block reduced however the intra-operative
anaesthetic requirement and a levo-bupivacaine block
provides similar beneficial intra-operative effects but
reduced also the need for rescue analgesics during the first
24 hours as compared to the lidocaine block.
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